All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for CHILDREN'S HEALTHCARE OF ATLANTA · Pediatric health care system

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 18, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Georgia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally

Budget/Appropriations

Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare

Bills named in this filing 3

H.R. 2107
Children’s Hospital GME Support Reauthorization Act of 2025
H.R. 1
One Big Beautiful Bill Act
H.R. 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.